In our study, overexpression of ADAM12 enhanced proliferation and inhibited apoptosis by downregulating caspase-specific activities, and acted as a positive regulator of cell cycle progression via the upregulation of cyclins and CDKs and the downregulation of CDK inhibitors in human CRC cells. Here, ADAM12 is linked to colorectal carcinoma.